The Scientist

» ebola and cell & molecular biology

Most Recent

image: NIH To Speed Ebola Vax Trials

NIH To Speed Ebola Vax Trials

By | September 2, 2014

The ongoing Ebola outbreak has prompted the National Institutes of Health to accelerate human trials of multiple Ebola vaccines, starting this week.

0 Comments

image: Experimental Ebola Drug Shows Promise

Experimental Ebola Drug Shows Promise

By | September 2, 2014

ZMapp effectively rescued macaques from Ebola in a small trial, but it could be several months before supplies of the drug meet the growing human demand for it.

1 Comment

image: Crossing Boundaries

Crossing Boundaries

By | September 1, 2014

A groundbreaker in the study of Listeria monocytogenes, Pascale Cossart continues to build her research tool kit to understand how to fight such intracellular human pathogens.

0 Comments

image: Entry Requirements

Entry Requirements

By | September 1, 2014

Recent developments in cell transfection and molecular delivery technologies

0 Comments

image: Head Scratchers

Head Scratchers

By | September 1, 2014

Many natural phenomena elude our understanding.

5 Comments

image: Speaking of Science

Speaking of Science

By | September 1, 2014

September 2014's selection of notable quotes

0 Comments

image: Ebola Outbreak Strains Sequenced

Ebola Outbreak Strains Sequenced

By | August 28, 2014

Ninety-nine publicly available genomes could help researchers working to develop diagnostics, vaccines, and therapies. 

4 Comments

image: Ebola’s Toll on Healthcare Workers

Ebola’s Toll on Healthcare Workers

By | August 26, 2014

“Unprecedented number of medical staff infected with Ebola,” the World Health Organization says.

2 Comments

image: Social Data for Ebola Surveillance

Social Data for Ebola Surveillance

By | August 26, 2014

Algorithms that map social media posts and mobile phone data can help researchers track epidemics.

0 Comments

image: Marburg Drug Shows Promise

Marburg Drug Shows Promise

By | August 22, 2014

Monkeys infected with lethal doses of Marburg virus were rescued by an experimental siRNA-based therapeutic, a study shows.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. Does Productivity Diminish Research Quality?
  3. How Plants Evolved Different Ways to Make Caffeine
  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech